“The Company is now actively seeking large pharmaceutical investors or companies to partner with us in developing and commercialising this research.
If they are so confident about their research results big pharma would be falling all over themselves to get on board. This will either lead to further dilution if they partner, or no interest if the results don't stack up commercially to other players with deep pockets.
Still a long long way to go.
CGB Price at posting:
0.9¢ Sentiment: None Disclosure: Held